Microencapsulated feeder cells as a source of soluble factors for expansion of CD34+ hematopoietic stem cells
β Scribed by Nanae Fujimoto; Satoshi Fujita; Takashi Tsuji; Junya Toguchida; Kenji Ida; Hiroshi Suginami; Hiroo Iwata
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 917 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0142-9612
No coin nor oath required. For personal study only.
β¦ Synopsis
Expansion of hematopoietic stem cells (HSCs) from cord blood is highly desired for treatment and transplantation of adult patients for hematologic diseases. For efficient proliferation of HSCs, CD34(+) cells from cord blood were co-cultured with microencapsulated murine stromal cells (HESS-5) or immortalized human mesenchymal stem cells (MSCs) in their conditioned media (CM). Bioactive substances for HSC proliferation in CM at the onset of culture are likely consumed by HSCs with time, and co-culturing with microencapsulated feeder cells ensures a continuous supply. The cell number of CD34(+) cell progeny efficiently increased under these culture conditions, and progeny were analyzed by flow cytometry, the colony assay and the cobblestone area-forming cell (CAFC) assay. Total nucleated cells and CD34(+) cell number increased 194- and 7.4-fold, respectively, in the presence of microencapsulated HESS-5 in CM. Colony forming cells and CAFCs were well maintained. The effective expansion of total cells and maintenance of primitive progenitor cells suggest that transfusion of the progeny obtained from CD34(+) cell culture with microencapsulated HESS-5 in CM could shorten the time to engraftment by bridging the pancytopenic period and support functional hematopoietic repopulation.
π SIMILAR VOLUMES
reported to have specific effect on megakaryocytopoiesis and enhance platelet recovery post chemotherapy. A mixture of growth factors are being evaluated for the ex vivo of periphera! progenitor cells to further reduce the period of marrow aplasia post therapy. Recombinant proteins are also helpful
A variety of adult stem cells have been used to transplant into the infarcted (MI) heart, however, comparative studies are lacking to show more suitable source of cells for transplantation. We have identified a single non-hematopoietic mesenchymal stem cell subpopulation (snMSCs) isolated from human
## Abstract It is expected that human neural stem/progenitor cells (hNS/PCs) will some day be used in cell replacement therapies. However, their availability is limited because of ethical issues, so they have to be expanded to obtain sufficient amounts for clinical application. Moreover, inβvitroβm